In the headlines or behind the scenes, CAMH stories always aim to inform, engage, and enlighten.

CAMH/ICES study shows reduction in suicide in depressed patients that receive ECT
About Electroconvulsive therapy reduces suicide by 50 per cent in first year after hospitalization for depression
Nearly 1 in 5 report contemplating suicide last year
About Majority of Ontario students surveyed report feeling depressed about the future because of COVID 19
2SLGBTQ+ inclusive and trauma-informed workers staffed the clinic, a key recommendation of a CAMH-led study.
About CAMH hosts vaccine clinic for 2SLGBTQ+ individuals
A collaborative effort between an artist (and Gifts of Light vendor), a Recreation Therapist and CAMH patients has revitalized clinical spaces and brought comfort to those seeking treatment
About Colour Connects
CAMH-led clinical trial provides further evidence for widespread use of pharmacogenetic testing in prescribing anti-depressants
About Pharmacogenetic testing shows promise improving symptoms in patients with treatment-resistant depression
New findings reveal which nutraceuticals and phytoceuticals are beneficial in the management of a range of mental health disorders.
About Global commission: new clinical guidelines for mental health and the use of nutraceuticals and medicinal plants
CAMH scientists have created the world’s first model of human brain microcircuitry that incorporates the properties of live human brain cells
About Conversation with CAMH scientist Etay Hay on brain cell networks and mental illness
CAMH’s Toronto Adolescent & Youth (TAY) CAMH Cohort Study
About Investigating the mystery of youth psychosis
SAPACCY is providing trauma-informed support to Black youth who are dealing with mental health and substance use concerns.
About Mental health program supporting Black youth is expanding after years of advocacy
Repetitive transcranial magnetic stimulation (rTMS) associated with up to 60 per cent reduction in cannabis use in CAMH-led clinical trial
About Brain stimulation shows promise as treatment for cannabis use disorder in people with schizophrenia